SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Downloaden Sie, um offline zu lesen
2010
KYRGYZSTAN:in prospect
Kyrgyzstan Pharmaceutical Market
The access to the pharmaceutical marketplace of any region is always paired with risks,
challenges and political, financial and economical factors specific to each region.
The Government of Kyrgyzstan aims to improve population health, reduce          there is a shortage of personnel in remote areas.
the financial burden of seeking care, and improve the quality of health care    Maternal mortality rate has increased soon after independence and remains
services. The reforms were initiated in 1996 with the “Manas National           at high level. Poverty is an important health determinant; infant mortality
Health Care Reform Program” which outlined the vision of change for 10          rates are 1.8 times higher in the 20% poorest households than in the
years. In 2005, evaluations of the reforms identified substantial progress as   wealthiest 20%. A long tradition of childhood immunization with good
well as continuing challenges and remaining tasks. The activities of the        coverage of the Expanded Programme on Immunizations (EPI) vaccines has
original Manas reforms are now being carried forward under the “Manas           been maintained.
Taalimi National Health Reform Program” for 2006-2010. The new Program
                                                                                Leading morbidity causes are respiratory (23.8% in 2007) and urogenital
has been approved at the highest government level, and supported by the
                                                                                system diseases (12.8% in 2007).
international community through a Sector-Wide Approach (SWAp). Both
the first Manas reform plan and its successor focus on a set of                 Main causes of mortality are cardiovascular diseases (48.3% in 2007), injuries
comprehensive changes in the organization, financing and content of the         and poisoning (9.8% in 2007) respiratory diseases (9.4% in 2007), and cancers
health system.                                                                  (7.9% in 2007).
Health financing reforms eliminated fragmentation which was inherent in         Tuberculosis remains an important disease, particularly in prisons
the previously decentralized financing system. This was accomplished            (incidence rate over 40 times greater than in general population) where
through the creation of regional purchasing pools (and from 2006, a single      multidrug-resistant tuberculosis is a major problem. Syphilis and gonorrhea
national pool) under the Mandatory Health Insurance Fund for allocation of      increased until 1997 and decreased since 2000. HIV/AIDS incidence has
resources using output-based strategic purchasing methods, a radical            increased, particularly in the southern part of the country along the
change from the previous input-based budgeting process based on                 opium/heroin trade routes. According to the United Nations Office for
allocations decided centrally. Simultaneously, and in part due to the change    Drug Control and Crime Prevention 2001 survey, drug addicts totaled 2% of
of incentives and the Law on Health Care which gave greater autonomy to         the total population, mainly males. Waterborne diseases are common due to
providers, hospital downsizing occurred and led to savings on utilities and     widespread contamination of water sources.
other fixed costs.
Primary care services have been reorganized in Family Group Practices
(FGPs), which by 2004 had enrolled approximately 98.5% of the population.       Kyrgyzstan:in prospect is available
An outpatient drug benefit has been introduced to improve access to
medicines for primary care management of conditions such as hypertension
                                                                                at Euros 145.00
and to reduce unnecessary hospitalizations. Despite continuous increases in     To know more about our report or to discuss this topic further
funding for primary health care, salaries for healthcare staff remain low and   please do not hesitate to contact us
                                                                                Tel/Fax: +38 044 206 17 17/18
                                                                                e-mail: office@smd.net.ua
Kyrgyzstan:in prospect
                                                                                                           EECCA: Region Features
                                                                                                           Economic Development
                                                                                                           Pharmaceutical Market: Executive Summary
                                                                                                           Pharmaceutical Market: Main Features
                                                                                                           Pharmaceutical Market: Structure
                                                                                                           Per capita expenses
                                                                                                           Kyrgyzstan
                                                                                                           Country profile
                                                                                                           Economy
                                                                                                           Healthcare system features
                                                                                                           Healthcare system funding
                                                                                                           Financial flows within the national health system
                                                                                                           Trends in healthcare expenditure, 2003-2007
                                                                                                           Structure of total healthcare expenditure 2001-2009
                                                                                                           Kyrgyzstan: Pharma Market
                                                                                                           Main features
                                                                                                           Weighted average cost of a pack by segments
                                                                                                           ATC 1 share. Total market, USD
                                                                                                           ATC 1 share. Total market, Units
                                                                                                           ATC 1 share. Rx segment, USD
                                                                                                           ATC 1 share. Rx segment, Units
DISCLAIMER                                                                                                 ATC 1 share. OTC segment, USD
All information contained in this publication
has been researched and compiled from sources                                                              ATC 1 share. OTC segment, Units
believed to be accurate and reliable at the time                                                           Leading corporations. Total market, USD
of publishing. However, SMD accepts no
liability whatsoever for any loss or damage                                                                Leading corporations. Total market, Units
resulting from errors, inaccuracies or omissions                                                           Leading corporations. Rx segment, USD
affecting any part of the publication. All
information is provided without warranty, and
                                                                                                           Leading corporations. Rx segment, Units
SMD makes no representation of warranty of                                                                 Leading corporations. OTC segment, USD
any kind as to the accuracy or completeness of
any information hereto contained.
                                                                                                           Leading corporations. OTC segment, Units
                                                                                                           Kyrgyzstan: Forecast for 2011-2013
Kyrgyzstan:in prospect                                                                                     Pharma market, USD
© 2011 SMD
All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of
this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means
graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means,
without the express written consent of the publisher.
SMD (Support in Market Development) - is a leading provider of market research,
sales management and forecasting services to the pharmaceutical industry.

Researches of:
· Pharmaceutics establishments' purchase and sale audit
· Hospital establishments' purchase audit
· Second distribution audit                                                Ukraine, 03680
· Import medicine analyses                                         Bojenko str., 86i, Kiev
· Doctor prescription analyses                             Tel/Fax: +38 044 206 17 17/18
· Ad Hoc research                                              e-mail: office@smd.net.ua
· Analytical services                                           http://www.smd.net.ua




                                  Kyrgyzstan:in prospect
                                                                                  April 2011

Weitere ähnliche Inhalte

Was ist angesagt?

Healthcare, Regulatory and Reimbursement Landscape - Morocco
Healthcare, Regulatory and Reimbursement Landscape - MoroccoHealthcare, Regulatory and Reimbursement Landscape - Morocco
Healthcare, Regulatory and Reimbursement Landscape - Morocco
ReportsnReports
 
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
ReportsnReports
 
NP_June2012_Kazakh_Heathcare_ST
NP_June2012_Kazakh_Heathcare_STNP_June2012_Kazakh_Heathcare_ST
NP_June2012_Kazakh_Heathcare_ST
ironstone69
 
Opportunities for the U.S. Medical Equipment Sector
Opportunities for the U.S. Medical Equipment SectorOpportunities for the U.S. Medical Equipment Sector
Opportunities for the U.S. Medical Equipment Sector
Liliana Carrillo
 
The Pharmaceutical Market: Canada
The Pharmaceutical Market: CanadaThe Pharmaceutical Market: Canada
The Pharmaceutical Market: Canada
James Parker
 
Vietnam Pharmaceutical Industry And Investment Strategy
Vietnam Pharmaceutical Industry And Investment StrategyVietnam Pharmaceutical Industry And Investment Strategy
Vietnam Pharmaceutical Industry And Investment Strategy
Vinh Nguyen
 
report-building-platform-gpp-macedonia
report-building-platform-gpp-macedoniareport-building-platform-gpp-macedonia
report-building-platform-gpp-macedonia
Jasminka Patceva
 
European union’s medical technology market by emanuel baisire
European union’s medical technology market by emanuel baisireEuropean union’s medical technology market by emanuel baisire
European union’s medical technology market by emanuel baisire
Emanuel Baisire
 
Health Care Industry in Tatarstan & Russia
Health Care Industry in Tatarstan & RussiaHealth Care Industry in Tatarstan & Russia
Health Care Industry in Tatarstan & Russia
InvestTatarstan
 
The greatest challenges in Russian health care
The greatest challenges in Russian health careThe greatest challenges in Russian health care
The greatest challenges in Russian health care
Bachinskaya
 

Was ist angesagt? (20)

Georgia Pharmaceutical Country Report 2019 FY
Georgia Pharmaceutical Country Report 2019 FYGeorgia Pharmaceutical Country Report 2019 FY
Georgia Pharmaceutical Country Report 2019 FY
 
Uzbekistan Pharmaceutical Country Report 9M 2019
Uzbekistan Pharmaceutical Country Report 9M 2019Uzbekistan Pharmaceutical Country Report 9M 2019
Uzbekistan Pharmaceutical Country Report 9M 2019
 
Healthcare, Regulatory and Reimbursement Landscape - Morocco
Healthcare, Regulatory and Reimbursement Landscape - MoroccoHealthcare, Regulatory and Reimbursement Landscape - Morocco
Healthcare, Regulatory and Reimbursement Landscape - Morocco
 
Upharmacia - Ukrainian Pharma Market News Digest. February 2016
Upharmacia - Ukrainian Pharma Market News Digest. February 2016Upharmacia - Ukrainian Pharma Market News Digest. February 2016
Upharmacia - Ukrainian Pharma Market News Digest. February 2016
 
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2018 ...
 
NP_June2012_Kazakh_Heathcare_ST
NP_June2012_Kazakh_Heathcare_STNP_June2012_Kazakh_Heathcare_ST
NP_June2012_Kazakh_Heathcare_ST
 
Azerbaijan Pharmaceutical Country Report 2019 FY
Azerbaijan Pharmaceutical Country Report 2019 FYAzerbaijan Pharmaceutical Country Report 2019 FY
Azerbaijan Pharmaceutical Country Report 2019 FY
 
Opportunities for the U.S. Medical Equipment Sector
Opportunities for the U.S. Medical Equipment SectorOpportunities for the U.S. Medical Equipment Sector
Opportunities for the U.S. Medical Equipment Sector
 
The Pharmaceutical Market: Canada
The Pharmaceutical Market: CanadaThe Pharmaceutical Market: Canada
The Pharmaceutical Market: Canada
 
Pharmaceutical market in Vietnam
Pharmaceutical market in VietnamPharmaceutical market in Vietnam
Pharmaceutical market in Vietnam
 
Vietnam Pharmaceutical Industry And Investment Strategy
Vietnam Pharmaceutical Industry And Investment StrategyVietnam Pharmaceutical Industry And Investment Strategy
Vietnam Pharmaceutical Industry And Investment Strategy
 
report-building-platform-gpp-macedonia
report-building-platform-gpp-macedoniareport-building-platform-gpp-macedonia
report-building-platform-gpp-macedonia
 
Armenia Pharmaceutical Country Report 2019 FY
Armenia Pharmaceutical Country Report 2019 FYArmenia Pharmaceutical Country Report 2019 FY
Armenia Pharmaceutical Country Report 2019 FY
 
Challenges Vietnam Pharmaceutical
Challenges Vietnam PharmaceuticalChallenges Vietnam Pharmaceutical
Challenges Vietnam Pharmaceutical
 
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system e...
 
European union’s medical technology market by emanuel baisire
European union’s medical technology market by emanuel baisireEuropean union’s medical technology market by emanuel baisire
European union’s medical technology market by emanuel baisire
 
Vietnam – Pharmaceuticals – 2015
Vietnam – Pharmaceuticals – 2015Vietnam – Pharmaceuticals – 2015
Vietnam – Pharmaceuticals – 2015
 
Health Care Industry in Tatarstan & Russia
Health Care Industry in Tatarstan & RussiaHealth Care Industry in Tatarstan & Russia
Health Care Industry in Tatarstan & Russia
 
The greatest challenges in Russian health care
The greatest challenges in Russian health careThe greatest challenges in Russian health care
The greatest challenges in Russian health care
 
Global Pharma Market
Global Pharma MarketGlobal Pharma Market
Global Pharma Market
 

Ähnlich wie Kyrgyzstan pharmaceutical market 2010

Martec China Medical Reform
Martec China Medical ReformMartec China Medical Reform
Martec China Medical Reform
kaiguo1999
 
Naoki Ikegami: How does Japan do it
Naoki Ikegami: How does Japan do itNaoki Ikegami: How does Japan do it
Naoki Ikegami: How does Japan do it
Nuffield Trust
 
10 04 28_whitepaper_hospital_costs_final
10 04 28_whitepaper_hospital_costs_final10 04 28_whitepaper_hospital_costs_final
10 04 28_whitepaper_hospital_costs_final
Duong Huyen
 
Oracle - 9iun2011
Oracle - 9iun2011Oracle - 9iun2011
Oracle - 9iun2011
Agora Group
 
Summary Bangladesh National Health Accounts 1997-2012
Summary Bangladesh National Health Accounts 1997-2012Summary Bangladesh National Health Accounts 1997-2012
Summary Bangladesh National Health Accounts 1997-2012
Policy Adda
 
National Health Accounts: What do they Reveal in Cote d'Ivoire?
National Health Accounts: What do they Reveal in Cote d'Ivoire?National Health Accounts: What do they Reveal in Cote d'Ivoire?
National Health Accounts: What do they Reveal in Cote d'Ivoire?
Health Systems 20/20
 
Regionalization Lessons from pharmacos that have 'tasted the crab'
Regionalization Lessons from pharmacos that have 'tasted the crab'Regionalization Lessons from pharmacos that have 'tasted the crab'
Regionalization Lessons from pharmacos that have 'tasted the crab'
Ari Silverman
 
Policy Framework for the Introduction of Budget Norms in the Health Sector an...
Policy Framework for the Introduction of Budget Norms in the Health Sector an...Policy Framework for the Introduction of Budget Norms in the Health Sector an...
Policy Framework for the Introduction of Budget Norms in the Health Sector an...
Jean-Marc Lepain
 

Ähnlich wie Kyrgyzstan pharmaceutical market 2010 (20)

Martec China Medical Reform
Martec China Medical ReformMartec China Medical Reform
Martec China Medical Reform
 
Naoki Ikegami: How does Japan do it
Naoki Ikegami: How does Japan do itNaoki Ikegami: How does Japan do it
Naoki Ikegami: How does Japan do it
 
10 04 28_whitepaper_hospital_costs_final
10 04 28_whitepaper_hospital_costs_final10 04 28_whitepaper_hospital_costs_final
10 04 28_whitepaper_hospital_costs_final
 
Vietnam Medical Device Industry 2009 - www.solidiance.com
Vietnam Medical Device Industry 2009 - www.solidiance.comVietnam Medical Device Industry 2009 - www.solidiance.com
Vietnam Medical Device Industry 2009 - www.solidiance.com
 
India pharmaceutical sector
India pharmaceutical sectorIndia pharmaceutical sector
India pharmaceutical sector
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in Jordan
 
MR consulting
MR consulting MR consulting
MR consulting
 
Oracle - 9iun2011
Oracle - 9iun2011Oracle - 9iun2011
Oracle - 9iun2011
 
Healthcare Landscape in Thailand, An Overview - Aug 2014
Healthcare Landscape in Thailand, An Overview - Aug 2014Healthcare Landscape in Thailand, An Overview - Aug 2014
Healthcare Landscape in Thailand, An Overview - Aug 2014
 
Summary Bangladesh National Health Accounts 1997-2012
Summary Bangladesh National Health Accounts 1997-2012Summary Bangladesh National Health Accounts 1997-2012
Summary Bangladesh National Health Accounts 1997-2012
 
Pharma marketing & policies
Pharma marketing & policiesPharma marketing & policies
Pharma marketing & policies
 
National Health Accounts: What do they Reveal in Cote d'Ivoire?
National Health Accounts: What do they Reveal in Cote d'Ivoire?National Health Accounts: What do they Reveal in Cote d'Ivoire?
National Health Accounts: What do they Reveal in Cote d'Ivoire?
 
Abstract Report Oncology
Abstract Report OncologyAbstract Report Oncology
Abstract Report Oncology
 
Regionalization Lessons from pharmacos that have 'tasted the crab'
Regionalization Lessons from pharmacos that have 'tasted the crab'Regionalization Lessons from pharmacos that have 'tasted the crab'
Regionalization Lessons from pharmacos that have 'tasted the crab'
 
Policy Framework for the Introduction of Budget Norms in the Health Sector an...
Policy Framework for the Introduction of Budget Norms in the Health Sector an...Policy Framework for the Introduction of Budget Norms in the Health Sector an...
Policy Framework for the Introduction of Budget Norms in the Health Sector an...
 
Health Financing in Kenya - The case of Wajir, Mandera, Turkana, Meru and Bun...
Health Financing in Kenya - The case of Wajir, Mandera, Turkana, Meru and Bun...Health Financing in Kenya - The case of Wajir, Mandera, Turkana, Meru and Bun...
Health Financing in Kenya - The case of Wajir, Mandera, Turkana, Meru and Bun...
 
Generic medicines ga
Generic medicines gaGeneric medicines ga
Generic medicines ga
 
Egypt Connected Healthcare Market Analysis Sample Report
Egypt Connected Healthcare Market Analysis Sample ReportEgypt Connected Healthcare Market Analysis Sample Report
Egypt Connected Healthcare Market Analysis Sample Report
 
GCC Dermatology Drugs Market Analysis
GCC Dermatology Drugs Market AnalysisGCC Dermatology Drugs Market Analysis
GCC Dermatology Drugs Market Analysis
 
Health Financing Profile: Ethiopia
Health Financing Profile: EthiopiaHealth Financing Profile: Ethiopia
Health Financing Profile: Ethiopia
 

Kürzlich hochgeladen

{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
hyt3577
 
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost LoverPowerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
PsychicRuben LoveSpells
 
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
Faga1939
 

Kürzlich hochgeladen (20)

BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
 
Julius Randle's Injury Status: Surgery Not Off the Table
Julius Randle's Injury Status: Surgery Not Off the TableJulius Randle's Injury Status: Surgery Not Off the Table
Julius Randle's Injury Status: Surgery Not Off the Table
 
Transformative Leadership: N Chandrababu Naidu and TDP's Vision for Innovatio...
Transformative Leadership: N Chandrababu Naidu and TDP's Vision for Innovatio...Transformative Leadership: N Chandrababu Naidu and TDP's Vision for Innovatio...
Transformative Leadership: N Chandrababu Naidu and TDP's Vision for Innovatio...
 
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
 
Group_5_US-China Trade War to understand the trade
Group_5_US-China Trade War to understand the tradeGroup_5_US-China Trade War to understand the trade
Group_5_US-China Trade War to understand the trade
 
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
 
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopkoEmbed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
 
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
 
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort ServiceBusty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
 
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost LoverPowerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
Powerful Love Spells in Phoenix, AZ (310) 882-6330 Bring Back Lost Lover
 
Defensa de JOH insiste que testimonio de analista de la DEA es falso y solici...
Defensa de JOH insiste que testimonio de analista de la DEA es falso y solici...Defensa de JOH insiste que testimonio de analista de la DEA es falso y solici...
Defensa de JOH insiste que testimonio de analista de la DEA es falso y solici...
 
06052024_First India Newspaper Jaipur.pdf
06052024_First India Newspaper Jaipur.pdf06052024_First India Newspaper Jaipur.pdf
06052024_First India Newspaper Jaipur.pdf
 
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
 
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
THE OBSTACLES THAT IMPEDE THE DEVELOPMENT OF BRAZIL IN THE CONTEMPORARY ERA A...
 
China's soft power in 21st century .pptx
China's soft power in 21st century   .pptxChina's soft power in 21st century   .pptx
China's soft power in 21st century .pptx
 
BDSM⚡Call Girls in Sector 135 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 135 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 135 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 135 Noida Escorts >༒8448380779 Escort Service
 
Embed-4.pdf lkdiinlajeklhndklheduhuekjdh
Embed-4.pdf lkdiinlajeklhndklheduhuekjdhEmbed-4.pdf lkdiinlajeklhndklheduhuekjdh
Embed-4.pdf lkdiinlajeklhndklheduhuekjdh
 
Nurturing Families, Empowering Lives: TDP's Vision for Family Welfare in Andh...
Nurturing Families, Empowering Lives: TDP's Vision for Family Welfare in Andh...Nurturing Families, Empowering Lives: TDP's Vision for Family Welfare in Andh...
Nurturing Families, Empowering Lives: TDP's Vision for Family Welfare in Andh...
 
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
 
1971 war india pakistan bangladesh liberation.ppt
1971 war india pakistan bangladesh liberation.ppt1971 war india pakistan bangladesh liberation.ppt
1971 war india pakistan bangladesh liberation.ppt
 

Kyrgyzstan pharmaceutical market 2010

  • 2. Kyrgyzstan Pharmaceutical Market The access to the pharmaceutical marketplace of any region is always paired with risks, challenges and political, financial and economical factors specific to each region. The Government of Kyrgyzstan aims to improve population health, reduce there is a shortage of personnel in remote areas. the financial burden of seeking care, and improve the quality of health care Maternal mortality rate has increased soon after independence and remains services. The reforms were initiated in 1996 with the “Manas National at high level. Poverty is an important health determinant; infant mortality Health Care Reform Program” which outlined the vision of change for 10 rates are 1.8 times higher in the 20% poorest households than in the years. In 2005, evaluations of the reforms identified substantial progress as wealthiest 20%. A long tradition of childhood immunization with good well as continuing challenges and remaining tasks. The activities of the coverage of the Expanded Programme on Immunizations (EPI) vaccines has original Manas reforms are now being carried forward under the “Manas been maintained. Taalimi National Health Reform Program” for 2006-2010. The new Program Leading morbidity causes are respiratory (23.8% in 2007) and urogenital has been approved at the highest government level, and supported by the system diseases (12.8% in 2007). international community through a Sector-Wide Approach (SWAp). Both the first Manas reform plan and its successor focus on a set of Main causes of mortality are cardiovascular diseases (48.3% in 2007), injuries comprehensive changes in the organization, financing and content of the and poisoning (9.8% in 2007) respiratory diseases (9.4% in 2007), and cancers health system. (7.9% in 2007). Health financing reforms eliminated fragmentation which was inherent in Tuberculosis remains an important disease, particularly in prisons the previously decentralized financing system. This was accomplished (incidence rate over 40 times greater than in general population) where through the creation of regional purchasing pools (and from 2006, a single multidrug-resistant tuberculosis is a major problem. Syphilis and gonorrhea national pool) under the Mandatory Health Insurance Fund for allocation of increased until 1997 and decreased since 2000. HIV/AIDS incidence has resources using output-based strategic purchasing methods, a radical increased, particularly in the southern part of the country along the change from the previous input-based budgeting process based on opium/heroin trade routes. According to the United Nations Office for allocations decided centrally. Simultaneously, and in part due to the change Drug Control and Crime Prevention 2001 survey, drug addicts totaled 2% of of incentives and the Law on Health Care which gave greater autonomy to the total population, mainly males. Waterborne diseases are common due to providers, hospital downsizing occurred and led to savings on utilities and widespread contamination of water sources. other fixed costs. Primary care services have been reorganized in Family Group Practices (FGPs), which by 2004 had enrolled approximately 98.5% of the population. Kyrgyzstan:in prospect is available An outpatient drug benefit has been introduced to improve access to medicines for primary care management of conditions such as hypertension at Euros 145.00 and to reduce unnecessary hospitalizations. Despite continuous increases in To know more about our report or to discuss this topic further funding for primary health care, salaries for healthcare staff remain low and please do not hesitate to contact us Tel/Fax: +38 044 206 17 17/18 e-mail: office@smd.net.ua
  • 3. Kyrgyzstan:in prospect EECCA: Region Features Economic Development Pharmaceutical Market: Executive Summary Pharmaceutical Market: Main Features Pharmaceutical Market: Structure Per capita expenses Kyrgyzstan Country profile Economy Healthcare system features Healthcare system funding Financial flows within the national health system Trends in healthcare expenditure, 2003-2007 Structure of total healthcare expenditure 2001-2009 Kyrgyzstan: Pharma Market Main features Weighted average cost of a pack by segments ATC 1 share. Total market, USD ATC 1 share. Total market, Units ATC 1 share. Rx segment, USD ATC 1 share. Rx segment, Units DISCLAIMER ATC 1 share. OTC segment, USD All information contained in this publication has been researched and compiled from sources ATC 1 share. OTC segment, Units believed to be accurate and reliable at the time Leading corporations. Total market, USD of publishing. However, SMD accepts no liability whatsoever for any loss or damage Leading corporations. Total market, Units resulting from errors, inaccuracies or omissions Leading corporations. Rx segment, USD affecting any part of the publication. All information is provided without warranty, and Leading corporations. Rx segment, Units SMD makes no representation of warranty of Leading corporations. OTC segment, USD any kind as to the accuracy or completeness of any information hereto contained. Leading corporations. OTC segment, Units Kyrgyzstan: Forecast for 2011-2013 Kyrgyzstan:in prospect Pharma market, USD © 2011 SMD All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher.
  • 4. SMD (Support in Market Development) - is a leading provider of market research, sales management and forecasting services to the pharmaceutical industry. Researches of: · Pharmaceutics establishments' purchase and sale audit · Hospital establishments' purchase audit · Second distribution audit Ukraine, 03680 · Import medicine analyses Bojenko str., 86i, Kiev · Doctor prescription analyses Tel/Fax: +38 044 206 17 17/18 · Ad Hoc research e-mail: office@smd.net.ua · Analytical services http://www.smd.net.ua Kyrgyzstan:in prospect April 2011